Fascination About Hemgenix
Quantity of suitable individuals: CDEC talked about the uncertainty in the number of people with moderately critical to significant hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some people that are labeled as getting gentle or moderate disorder could have a extreme bleeding phe